{
     "PMID": "28752224",
     "OWN": "NLM",
     "STAT": "Publisher",
     "LR": "20170728",
     "IS": "1559-1182 (Electronic) 0893-7648 (Linking)",
     "DP": "2017 Jul 27",
     "TI": "Early Preclinical Changes in Hippocampal CREB-Binding Protein Expression in a Mouse Model of Familial Alzheimer's Disease.",
     "LID": "10.1007/s12035-017-0690-4 [doi]",
     "AB": "The molecular basis of memory loss in Alzheimer's disease (AD), the main cause of senile dementia, is under investigation. In the present study, we have focused on the early hippocampal memory-related changes in APPswe/PS1dE9 (APP/PS1) mice, a well-established mouse model of familial AD. It is well known that molecules like cAMP response element binding (CREB) and binding protein (CBP) play a crucial role in memory consolidation. We analyzed CBP on its transcriptional activity and protein levels, finding a significant downregulation of both of them at 3-month-old mice. In addition, the downregulation of this molecule was associated with a decrease on acetylation levels of histone H3 in the hippocampus of APP/PS1 mice. Moreover, the p-CREB levels, which are important for memory acquisition at 3 months in APP/PS1 mice, were downregulated. Furthermore, we suggest that early neuroinflammation, especially due to the Tnfalpha gene increased expression, could also be responsible to this process of memory loss. Given all the previously mentioned results, we propose that an early suitable treatment to prevent the evolution of the disease should include a combination of drugs, including anti-inflammatories, which may decrease glial activation and Tnfalpha levels, and phosphodiesterase inhibitors that increase cAMP levels.",
     "FAU": [
          "Ettcheto, Miren",
          "Abad, Sonia",
          "Petrov, Dmitry",
          "Pedros, Ignacio",
          "Busquets, Oriol",
          "Sanchez-Lopez, Elena",
          "Casadesus, Gemma",
          "Beas-Zarate, Carlos",
          "Carro, Eva",
          "Auladell, Carme",
          "Olloquequi, Jordi",
          "Pallas, Merce",
          "Folch, Jaume",
          "Camins, Antoni"
     ],
     "AU": [
          "Ettcheto M",
          "Abad S",
          "Petrov D",
          "Pedros I",
          "Busquets O",
          "Sanchez-Lopez E",
          "Casadesus G",
          "Beas-Zarate C",
          "Carro E",
          "Auladell C",
          "Olloquequi J",
          "Pallas M",
          "Folch J",
          "Camins A"
     ],
     "AD": "Departament de Farmacologia, Toxicologia I Quimica Terapeutica, Facultat de Farmacia i Ciencies de l'Alimentacio, Universitat de Barcelona, Barcelona, Spain. Departament de Bioquimica, Facultat de Medicina i Ciencies de la Salut, Universitat Rovira i Virgili, Reus, Spain. Biomedical Research Networking Center in Neurodegenerative Diseases (CIBERNED), Madrid, Spain. Institut de Neurociencies, Universitat de Barcelona, Barcelona, Spain. Departament de Farmacologia, Toxicologia I Quimica Terapeutica, Facultat de Farmacia i Ciencies de l'Alimentacio, Universitat de Barcelona, Barcelona, Spain. Biomedical Research Networking Center in Neurodegenerative Diseases (CIBERNED), Madrid, Spain. Departament de Farmacologia, Toxicologia I Quimica Terapeutica, Facultat de Farmacia i Ciencies de l'Alimentacio, Universitat de Barcelona, Barcelona, Spain. Biomedical Research Networking Center in Neurodegenerative Diseases (CIBERNED), Madrid, Spain. Departament de Bioquimica, Facultat de Medicina i Ciencies de la Salut, Universitat Rovira i Virgili, Reus, Spain. Biomedical Research Networking Center in Neurodegenerative Diseases (CIBERNED), Madrid, Spain. Departament de Farmacologia, Toxicologia I Quimica Terapeutica, Facultat de Farmacia i Ciencies de l'Alimentacio, Universitat de Barcelona, Barcelona, Spain. Departament de Bioquimica, Facultat de Medicina i Ciencies de la Salut, Universitat Rovira i Virgili, Reus, Spain. Biomedical Research Networking Center in Neurodegenerative Diseases (CIBERNED), Madrid, Spain. Institut de Neurociencies, Universitat de Barcelona, Barcelona, Spain. Unitat de Farmacia, Tecnologia Farmaceutica i Fisico-quimica, Facultat de Farmacia, Universitat de Barcelona, Barcelona, Spain. Institute of Nanoscience and Nanotechnology (IN2UB), University of Barcelona, Barcelona, Spain. Department of Biological Sciences, Kent State University, Kent, OH, USA. Departamento de Biologia Celular y Molecular, Laboratorio de Regeneracion y Desarrollo Neural, Instituto de Neurobiologia, CUCBA, Mexico. Biomedical Research Networking Center in Neurodegenerative Diseases (CIBERNED), Madrid, Spain. Neuroscience Group, Instituto de Investigacion Hospital 12 de Octubre, Madrid, Spain. Biomedical Research Networking Center in Neurodegenerative Diseases (CIBERNED), Madrid, Spain. Institut de Neurociencies, Universitat de Barcelona, Barcelona, Spain. Departament de Biologia Cel*lular, Fisiologia i Immunologia, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain. Instituto de Ciencias Biomedicas, Facultad de Ciencias de la Salud, Universidad Autonoma de Chile, Talca, Chile. Departament de Farmacologia, Toxicologia I Quimica Terapeutica, Facultat de Farmacia i Ciencies de l'Alimentacio, Universitat de Barcelona, Barcelona, Spain. Biomedical Research Networking Center in Neurodegenerative Diseases (CIBERNED), Madrid, Spain. Institut de Neurociencies, Universitat de Barcelona, Barcelona, Spain. Departament de Bioquimica, Facultat de Medicina i Ciencies de la Salut, Universitat Rovira i Virgili, Reus, Spain. Biomedical Research Networking Center in Neurodegenerative Diseases (CIBERNED), Madrid, Spain. Departament de Farmacologia, Toxicologia I Quimica Terapeutica, Facultat de Farmacia i Ciencies de l'Alimentacio, Universitat de Barcelona, Barcelona, Spain. camins@ub.edu. Biomedical Research Networking Center in Neurodegenerative Diseases (CIBERNED), Madrid, Spain. camins@ub.edu. Institut de Neurociencies, Universitat de Barcelona, Barcelona, Spain. camins@ub.edu. Unitat de Farmacologia i Farmacognosia, Facultat de Farmacia i Ciencies de l'Alimentacio, Universitat de Barcelona, Barcelona, Spain. Av. Joan XXIII s/n, E-08028, Barcelona, Spain. camins@ub.edu.",
     "AUID": [
          "ORCID: http://orcid.org/0000-0002-1229-5956"
     ],
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article"
     ],
     "DEP": "20170727",
     "PL": "United States",
     "TA": "Mol Neurobiol",
     "JT": "Molecular neurobiology",
     "JID": "8900963",
     "OTO": [
          "NOTNLM"
     ],
     "OT": [
          "APPSwe/PS1dE9",
          "Alzheimer disease",
          "CBP",
          "CREB",
          "Hippocampus"
     ],
     "EDAT": "2017/07/29 06:00",
     "MHDA": "2017/07/29 06:00",
     "CRDT": [
          "2017/07/29 06:00"
     ],
     "PHST": [
          "2017/02/15 00:00 [received]",
          "2017/07/12 00:00 [accepted]",
          "2017/07/29 06:00 [entrez]",
          "2017/07/29 06:00 [pubmed]",
          "2017/07/29 06:00 [medline]"
     ],
     "AID": [
          "10.1007/s12035-017-0690-4 [doi]",
          "10.1007/s12035-017-0690-4 [pii]"
     ],
     "PST": "aheadofprint",
     "SO": "Mol Neurobiol. 2017 Jul 27. pii: 10.1007/s12035-017-0690-4. doi: 10.1007/s12035-017-0690-4.",
     "term": "hippocampus"
}